Anti-inflammatory drug use and age-related macular degeneration

Optometry and Vision Science

Volumn 85, Issue 10, 2008, Pages 947-950

  Swanson, Mark W ^a   McGwin Jr , Gerald ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Age related macular degeneration; Anti inflammatory; Medication; Prevention

Indexed keywords

AGE-RELATED MACULAR DEGENERATION; ALABAMA; ANTI-INFLAMMATORY; ANTI-INFLAMMATORY DRUGS; BASIC RESEARCH; BIRMINGHAM; CASE-CONTROL STUDY; CONFIDENCE INTERVAL; INTERNATIONAL CLASSIFICATION OF DISEASE; MEDICAL CENTER; MEDICATION; ODDS RATIOS; PREVENTION;

HOSPITALS;

DIAGNOSIS;

ANTIINFLAMMATORY AGENT; CELECOXIB; DEXAMETHASONE; DICLOFENAC; DIFLUNISAL; FLUTICASONE; HYDROCORTISONE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID DERIVATIVE; STEROID;

AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; UNITED STATES; CASE CONTROL STUDY; RETINA MACULA DEGENERATION; STATISTICS; VETERAN;

AGED; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; DRUG PRESCRIPTIONS; HUMANS; MACULAR DEGENERATION; MALE; VETERANS;

EID: 58149214722     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e31818883e0     Document Type: Article

References (19)

1. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and etiological aspects of macular degeneration. Prog Retin Eye Res 2001;20:385-414.
2. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002;134:411-31.
3. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 2001;73:887-96.
4. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004;291:704-10.
5. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol 2003;121:674-8.
6. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and agerelated macular degeneration. Arch Ophthalmol 2003;121:478-82.
7. Drug Facts and Comparisons, 58th ed. St. Louis: Facts and Comparisons; 2004.
8. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006;296:301-9.
9. Ray KK, Cannon CP, Ganz P. Beyond lipid lowering: what have we learned about the benefits of statins from the acute coronary syndromes trials? Am J Cardiol 2006;98:18P-25.
10. Klein R, Klein BE, Jensen SC, Cruickshanks KJ, Lee KE, Danforth LG, Tomany SC. Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001;119:1354-9.
11. Klein R, Klein BE, Tomany SC, Danforth LG, Cruickshanks KJ. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 2003;121:1151-5.
12. Klein R, Klein BE. Do statins prevent age-related macular degeneration? Am J Ophthalmol 2004;137:747-9.
13. McGwin G Jr, Modjarrad K, Hall TA, Xie A, Owsley C. 3-Hydroxy- 3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch Ophthalmol 2006;124:33-7.
14. SmeethL,Cook C, ChakravarthyU, Hubbard R, Fletcher AE. A case control study of age related macular degeneration and use of statins. Br J Ophthalmol 2005;89:1171-5.
15. Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004;137:615-24.
16. McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. Br J Ophthalmol 2003;87:1121-5.
17. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, Manson JE, Hennekens CH. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 2001;119:1143-9.
18. Wang JJ, Mitchell P, Smith W, Gillies M, Billson F. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003;10:37-48.
19. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL III. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 2005;112:533-9.